Description
Recombinant monoclonal antibody to BCR-ABL. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 7c6.
Target
BCR-ABL
Target Alias Names
BCR/ABL, Breakpoint cluster region protein-tyrosine protein kinase ABL1 fusion protein
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression